Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SCAI publications committee manual of standard operating procedures.
Szerlip M, Feldman DN, Aronow HD, Blankenship JC, Choi JW, Elgendy IY, Elmariah S, Garcia S, Goldstein BH, Herrmann H, Hira RS, Jaff MR, Kalra A, Kaluski E, Kavinsky CJ, Kolansky DM, Kong DF, Messenger JC, Mukherjee D, Patel RAG, Piana R, Senerth E, Shishehbor M, Singh G, Singh V, Yadav PK, Cox D. Szerlip M, et al. Among authors: herrmann h. Catheter Cardiovasc Interv. 2020 Jul;96(1):145-155. doi: 10.1002/ccd.28754. Epub 2020 Feb 14. Catheter Cardiovasc Interv. 2020. PMID: 32061033
Three-year clinical follow-up after Palmaz-Schatz stenting.
Klugherz BD, DeAngelo DL, Kim BK, Herrmann HC, Hirshfeld JW, Kolansky DM. Klugherz BD, et al. Among authors: herrmann hc. J Am Coll Cardiol. 1996 Apr;27(5):1185-91. doi: 10.1016/0735-1097(95)00574-9. J Am Coll Cardiol. 1996. PMID: 8609340 Free article.
Combination therapy with clopidogrel and aspirin after coronary stenting.
Kolansky DM, Klugherz BD, Curran SC, Herrmann HC, Magness K, Wilensky RL, Hirshfeld JW Jr. Kolansky DM, et al. Among authors: herrmann hc. Catheter Cardiovasc Interv. 2000 Jul;50(3):276-9. doi: 10.1002/1522-726x(200007)50:3<276::aid-ccd2>3.0.co;2-p. Catheter Cardiovasc Interv. 2000. PMID: 10878621
One-year clinical outcomes of protected and unprotected left main coronary artery stenting.
Kelley MP, Klugherz BD, Hashemi SM, Meneveau NF, Johnston JM, Matthai WH Jr, Banka VS, Herrmann HC, Hirshfeld JW Jr, Kimmel SE, Kolansky DM, Horwitz PA, Schiele F, Bassand JP, Wilensky RL. Kelley MP, et al. Among authors: herrmann hc. Eur Heart J. 2003 Sep;24(17):1554-9. doi: 10.1016/s0195-668x(03)00314-2. Eur Heart J. 2003. PMID: 12927190
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.
Ross MJ, Herrmann HC, Moliterno DJ, Blankenship JC, Demopoulos L, DiBattiste PM, Ellis SG, Ghazzal Z, Martin JL, White J, Topol EJ. Ross MJ, et al. J Am Coll Cardiol. 2003 Sep 17;42(6):981-8. doi: 10.1016/s0735-1097(03)00913-6. J Am Coll Cardiol. 2003. PMID: 13678916 Free article. Clinical Trial.
Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure R, Moliterno D. Kalyanasundaram A, et al. Among authors: herrmann h. Catheter Cardiovasc Interv. 2007 Apr 1;69(5):623-9. doi: 10.1002/ccd.20963. Catheter Cardiovasc Interv. 2007. PMID: 17192960 Clinical Trial.
1,807 results